Distributive justice and the arrival of direct-acting antivirals: who should be first in line?
A Aronsohn, D Jensen - Hepatology, 2011 - journals.lww.com
In recent years, each edition of HEPATOLOGY has included a viewpoint article written by a
member of the Editorial team. This month Dr Michael Charlton has offered his turn at the
microphone to Dr. Donald Jensen and Dr Andrew Aronsohn from the University of Chicago,
in order that they can address a pressing issue that will emerge in tandem with the likely
approval by the US Food and Drug Administration of boceprevir and/or telaprevir.
member of the Editorial team. This month Dr Michael Charlton has offered his turn at the
microphone to Dr. Donald Jensen and Dr Andrew Aronsohn from the University of Chicago,
in order that they can address a pressing issue that will emerge in tandem with the likely
approval by the US Food and Drug Administration of boceprevir and/or telaprevir.